Catalyst Biosciences, Inc.


Catalyst Biosciences, Inc. Stock Quote
$5.37 -$0.03 -0.6%
Price as of August 6, 2020, 4:30 p.m. EDT View Interactive CBIO Charts

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Interactive Chart

News & Analysis: Catalyst Biosciences, Inc.


Last Week's Biggest Stock Laggards

The market roared ahead last week, but some stocks and sectors weren't able to keep up with the rest of the market.